Pharmacokinetics, safety, and tolerability of a new patritumab formulation in patients with advanced, refractory solid tumors.

被引：4
|
作者：
Papadopoulos, Kyriakos P.
Moore, Kathleen N.
Lush, Richard
Desai, Madhuri
Mahmood, Syed
Beckman, Robert A.
Mendell-Harary, Jeanne
机构：
[1] START South Texas Accelerated Res Therapeut LLC, San Antonio, TX USA
[2] Peggy & Charles Stephenson Oklahoma Canc Ctr, Oklahoma City, OK USA
[3] H Lee Moffitt Canc Ctr & Res Inst Inc, Tampa, FL USA
[4] Daiichi Sankyo, Edison, NJ USA
[5] Georgetown Univ, Med Ctr, Washington, DC 20007 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.e14026
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14026
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Safety, tolerability, and pharmacokinetics (PK) of rilotumumab in Japanese patients (pts) with advanced solid tumors.
    Doi, Toshihiko
    Tang, Rui
    Zhang, Yilong
    Loh, Elwyn
    Lizambri, Richard
    Yasui, Hirofumi
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [2] Safety and pharmacokinetics of AMG 706 in patients with advanced solid tumors.
    Rosen, L
    Kurzrock, R
    Jackson, E
    Wathen, L
    Parson, M
    Eschenberg, M
    Mulay, M
    Purdom, M
    Yan, L
    Herbst, RS
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 195S - 195S
  • [3] Phase I study of the pharmacokinetics and tolerability of everolimus in Chinese patients with advanced solid tumors.
    Xu, B.
    Shen, L.
    Ye, D.
    Jappe, A.
    Wang, H.
    Yuan, R.
    Wu, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [4] Safety and pharmacokinetics (PK) of AMG 706 in Japanese patients with advanced solid tumors.
    Fujisaka, Y
    Yamada, Y
    Yamamoto, N
    Shimizu, T
    Fujiwara, Y
    Yamada, K
    Tamura, T
    Wong, S
    Ohkura, M
    Seki, M
    Ohtsu, T
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 8965S - 8965S
  • [5] Phase I study to determine the safety and pharmacokinetics of BAY 43-9006 in patients with advanced refractory solid tumors.
    Hirte, H
    Moore, MJ
    Oza, AM
    Siu, LL
    Harris, H
    Maclean, M
    Petrenciuc, O
    Fiander, W
    Lathia, C
    CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3768S - 3768S
  • [6] Population Pharmacokinetics of Patritumab Deruxtecan in Patients With Solid Tumors
    Lu, Yasong
    Shimizu, Shinji
    Sawamura, Ryoko
    Tajima, Naoyuki
    He, Ling
    Lee, Mark
    Abutarif, Malaz
    Shi, Rong
    JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 63 (01): : 77 - 90
  • [7] Safety and tolerability of MEDI0562 in combination with durvalumab or tremelimumab in patients with advanced solid tumors.
    Goldman, Jonathan Wade
    Piha-Paul, Sarina Anne
    Curti, Brendan D.
    Pedersen, Katrina
    Bauer, Todd Michael
    Groenland, Stefanie L.
    Carvajal, Richard D.
    Chhaya, Vaishali
    Hammond, Scott A.
    Streicher, Katie
    Townsley, Danielle Michelle
    Chae, Young Kwang
    Voortman, Jens
    Marabelle, Aurelien
    Powderly, John D.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [8] Tolerability of split-dose oprozomib (ONX 0912) in patients with advanced refractory or recurrent solid tumors.
    Papadopoulos, Kyriakos P.
    Mendelson, David S.
    Tolcher, Anthony W.
    Burris, Howard A.
    Gordon, Michael S.
    Bomba, Darrin
    Gillenwater, Heidi H.
    Infante, Jeffrey R.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [9] Pharmacokinetics of orally administered rucaparib in patients with advanced solid tumors.
    Shapiro, Geoffrey
    Kristeleit, Rebecca
    Middleton, Mark
    Burris, Howard
    Molife, L. Rhoda
    Evans, Jeff
    Wilson, Richard
    LoRusso, Patricia
    Spicer, James
    Dieras, Veronique
    Patel, Manish
    Dominy, Erin
    Simpson, Dayna
    Giordano, Heidi
    Allen, Andrew R.
    Jaw-Tsai, Sarah S.
    Plummer, Ruth
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [10] Phase I study to assess the safety, tolerability, pharmacokinetics/pharmacodynamics and preliminary efficacy of SC10914 in patients with advanced solid tumors.
    Gong, Jifang
    Tang, Jinhai
    Yin, Yongmei
    Ye, Dingwei
    Zhang, Jian
    Zheng, Hong
    Gao, Yunong
    Jang, Haoyuan
    Chen, Xiao
    Zhang, Zhe
    Shen, Lin
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345